Evidence map›Paper›PMID 35408862›Full record

ReviewInternational journal of molecular sciences2022

Skin Microbiota in Atopic Dermatitis.

Dora Hrestak, Mario Matijašić, Hana Čipčić Paljetak, Daniela Ledić Drvar, Suzana Ljubojević Hadžavdić, Mihaela Perić

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Microbiome and its Association with Diseases of the Ear, Nose and Pharynx.Endocrine, metabolic & immune disorders drug targets · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Engineered Tissue Models to Decode Host-Microbiota Interactions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  11. Review
  12. Review
  13. Pathogens (Basel, Switzerland) · 2025
    Review
  14. Article
  15. Langerhans cells: Central players in the pathophysiology of atopic dermatitis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Review
  16. Frontiers in microbiology · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Transcriptional Profiling ofInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dora HrestakDepartment of Intercellular Communication, Center for Translational and Clinical Research, University of Zagreb School of Medicine, Šalata 2, 10000 Zagreb, Croatia.ORCID 0000-0001-6946-299X
Mario MatijašićDepartment of Intercellular Communication, Center for Translational and Clinical Research, University of Zagreb School of Medicine, Šalata 2, 10000 Zagreb, Croatia.ORCID 0000-0001-9209-4611
Hana Čipčić PaljetakDepartment of Intercellular Communication, Center for Translational and Clinical Research, University of Zagreb School of Medicine, Šalata 2, 10000 Zagreb, Croatia.ORCID 0000-0002-8837-3156
Daniela Ledić DrvarDepartment of Dermatology and Venereology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Kišpatićeva 12, 10000 Zagreb, Croatia.
Suzana Ljubojević HadžavdićDepartment of Dermatology and Venereology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Kišpatićeva 12, 10000 Zagreb, Croatia.
Mihaela PerićDepartment of Intercellular Communication, Center for Translational and Clinical Research, University of Zagreb School of Medicine, Šalata 2, 10000 Zagreb, Croatia.ORCID 0000-0002-1904-2193

Funding

Synergistic innovative combination of microbiota components as a basis for the development of innovative topical products for the treatment and prevention of inflammatory conditions of human skin (acronym PROBITECT) KK.01.2.1.02.0137
6 · The paper itself

Abstract

The skin microbiota represents an ecosystem composed of numerous microbial species interacting with each other, as well as with host epithelial and immune cells. The microbiota provides health benefits to the host by supporting essential functions of the skin and inhibiting colonization with pathogens. However, the disturbance of the microbial balance can result in dysbiosis and promote skin diseases, such as atopic dermatitis (AD). This review provides a current overview of the skin microbiota involvement in AD and its complex interplay with host immune response mechanisms, as well as novel therapeutic strategies for treating AD focused on restoring skin microbial homeostasis.

Indexed as

Dermatitis, AtopicMicrobiotaDysbiosisHumansImmunitySkinatopic dermatitisdysbiosisskin microbiota

Identifiers

PMID35408862
PMCPMC8998607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.